RNA-Editing Enzyme ADAR1 Attenuates Rheumatoid Arthritis via Regulating Fibroblast-Like Synoviocyte-Derived Exosomal circFTO
International Archives of Allergy and Immunology · 2025
DOI: 10.1159/000547802 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2025. Verfasst von Yuxuan Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Adenosine Deaminase, Exosomes, RNA-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
Rheumatoid arthritis (RA) is a chronic debilitating autoimmune disorder and a predominant cause of potentially treatable functional disability. Adenosine deaminase acting on RNA 1 (ADAR1), as an RNA-editing enzyme, can regulate circular RNAs and fibroblast-like synoviocyte (FLS)-derived exosomal circFTO has been proposed as a contributor to RA. This study was dedicated to elaborate the role of ADAR1 in RA and the association between ADAR1 and circFTO.
Methods
Reverse transcription-quantitative PCR (RT-qPCR) examined circFTO, fat mass, and obesity-associated protein (FTO), DExH-box helicase 9 (DHX9), ADAR1, and Quaking (QKI) expressions in RA-FLSs and human fibroblast-like synoviocytes (HFLSs), and circFTO expression in RA-FLS- or HFLS-derived exosomes. In severe combined immunodeficiency (SCID) mice engrafted with human cartilage and rheumatoid synovium tissue (SCID-HuRAg), the in vivo imaging technique was adopted to track the distribution and migration of RA-FLSs and HFLSs. Hematoxylin and eosin staining and Safranin-O staining measured the severity of RA and engrafted cartilage degradation. Immunohistochemistry assessed the expression of inflammation-, anabolic-, and catabolic-related genes. Also, RT-qPCR examined the expressions of circFTO, miR-548a-3p, heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1), anabolic- and catabolic-related genes.
Results
ADAR1 was lowly expressed in RA-FLSs and ADAR1 silencing reduced circFTO expression in RA-FLS-derived exosomes. In vivo, RA-FLSs were widely distributed, and the migration capability was enhanced compared with HFLSs. ADAR1 overexpression efficiently decreased arthritis severity and attenuated cartilage degradation and inflammatory response in SCID-HuRAg mice injected with RA-FLSs. Besides, ADAR1 could decrease circFTO and hnRNPA2B1 expressions while elevating miR-548a-3p expression, particularly in SCID-HuRAg mice injected with RA-FLSs.
Conclusion
To summarize, our findings identify ADAR1 as a potential treatment target for RA at least partially via regulating circFTO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
- Department of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China, ligq@yzu.edu.cn.
Zitieren
APA
Fang, Y., Xu, N., Shen, J., Chen, H., Ding, Y., & Li, G. (2025). RNA-Editing Enzyme ADAR1 Attenuates Rheumatoid Arthritis via Regulating Fibroblast-Like Synoviocyte-Derived Exosomal circFTO. International Archives of Allergy and Immunology. https://doi.org/10.1159/000547802
Vancouver
Fang Y, Xu N, Shen J, Chen H, Ding Y, Li G. RNA-Editing Enzyme ADAR1 Attenuates Rheumatoid Arthritis via Regulating Fibroblast-Like Synoviocyte-Derived Exosomal circFTO. International Archives of Allergy and Immunology. 2025. doi:10.1159/000547802
BibTeX
@article{Fang2025,
author = {Fang, Yuxuan and Xu, Nan and Shen, Jiacheng and Chen, Hongyi and Ding, Yimin and Li, Guoqing},
title = {RNA-Editing Enzyme ADAR1 Attenuates Rheumatoid Arthritis via Regulating Fibroblast-Like Synoviocyte-Derived Exosomal circFTO},
journal = {International Archives of Allergy and Immunology},
year = {2025},
doi = {10.1159/000547802}
}
EUVIMED